Mersana Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 24,533 | 0.0202% |
Individual Insiders | 1,497,937 | 1.23% |
General Public | 5,046,625 | 4.16% |
VC/PE Firms | 19,991,673 | 16.5% |
Hedge Funds | 35,482,971 | 29.3% |
Institutions | 59,259,268 | 48.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
19,364,688 | US$91.0m | 0% | 2.5% | |||
11,328,000 | US$53.2m | 0% | 2.37% | |||
9,698,147 | US$45.6m | 92.4% | 0.12% | |||
8,663,673 | US$40.7m | 0% | 2.99% | |||
7,844,282 | US$36.9m | -1.61% | no data | |||
6,420,136 | US$30.2m | 28.4% | 7.81% | |||
6,237,588 | US$29.3m | 0.83% | no data | |||
5,978,327 | US$28.1m | 0% | 5.07% | |||
4,128,150 | US$19.4m | 324% | no data | |||
3,394,440 | US$16.0m | 55.9% | 0.01% | |||
3,046,782 | US$14.3m | -10.5% | 0.38% | |||
2,368,000 | US$11.1m | 2,280% | 5.66% | |||
2,329,434 | US$10.9m | 0.72% | no data | |||
2,297,136 | US$10.8m | 6.46% | no data | |||
1,926,931 | US$9.1m | 19.3% | 0.01% | |||
1,305,000 | US$6.1m | 0% | 1.1% | |||
1,264,567 | US$5.9m | -46% | 1.19% | |||
1,139,407 | US$5.4m | 0% | 0.04% | |||
1,139,232 | US$5.4m | 1,710% | no data | |||
1,086,115 | US$5.1m | 0% | 0.06% | |||
1,000,000 | US$4.7m | -64.9% | 0.92% | |||
931,406 | US$4.4m | -9.62% | no data | |||
930,607 | US$4.4m | 0% | 0.02% | |||
865,731 | US$4.1m | -6.5% | 0.01% | |||
774,659 | US$3.6m | 164% | 0.6% |